EUROPE - European institutional investors are buying customised OTC and securitised equity derivative products with a view to selling them on to high-net-worth and other retail customers, Greenwich Associates' research has found.
According to a study of 167 institutions, the proportion of European institutional investors active in customised OTC, securitised and hybrid derivative products increased from slightly more than 7...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
